Navigation Links
First Patient from Abu Dhabi Arrives in South Korea for Medical Treatment
Date:1/10/2012

SEOUL, South Korea, Jan. 10, 2012 /PRNewswire-Asia/ -- The Ministry of Health and Welfare and Korea Health Industry Development Institute announced that the first patient referred from the Health Authority-Abu Dhabi (HAAD) arrived in South Korea on Dec. 20, 2011 and was successfully treated.

The Korean government arranged for domestic hospitals to sign a pact on patient referral and transfer with the Abu Dhabi when HAAD Chairman Mohammed Sultan Al Hameli and CEO Zaid Daoud Al Siksek visited South Korea on Nov. 25, 2011.

HAAD signed a pact with Samsung Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital and AsanMedicalCenter.

The first patient from Abu Dhabi is a male born in 1983 to received treatment at the Seoul National University Hospital. His vocal cords were damaged due to the use of respirators for prolonged periods during childhood. HAAD had granted treatment approval at the Seoul National University Hospital and announced later on, the patient had been successfully treated during the span of Dec. 21 to 23, 2011. The hospital provided the patient with the necessary medical services including airport pick-up/drop-off, interpretation and accommodations, among others.

HAAD has referred a second patient to AsanMedicalCenter, which will take over kidney transplantation procedures once the operation is confirmed feasible. The patient will visit South Korea with the donor. This patient was already considered "unlikely to be healed" by numerous American and British physicians. If the transplantation succeeds, it will provide an invaluable opportunity to show the world South Korea's advanced medical technique.

Similarly, the Dubai Health Authority (DHA) began to express strong interest in referring their patients to South Korean hospitals.

A pilot patient from Dubai, a male born in 1943, arrived in South Korea on Dec. 19, 2011 and received an edoscopic mucosal resection.

For more information about Medical Korea's Korea Medical Charity Program, please contact Mike Kim of the Korea Health Industry Development Institute's Global Healthcare Business Department at +82-2-538-0612 or koreaexport@naver.com.


'/>"/>
SOURCE Korea Health Industry Development Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Announces First Quarter 2012 Earnings Conference Call, Wednesday, January 25, 2012
2. Remedi SeniorCare® Wins Ohio State Board of Pharmacys First and Only Approval for Electronic Prescribing in State of Ohio
3. First and Only Meter to Look for Patterns of High and Low Blood Sugar and Alert Diabetes Patients Right on Screen
4. Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
5. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 First Quarter Earnings Webcast
6. Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea
7. First Ever InnoPack Event Has Strong Turn Out and a Focus on Innovation
8. Actavis First-To-Market with Generic Equivalents of Clobex® Shampoo and Clobex® Topical Lotion
9. Mylan Launches First Generic Version of Teveten® Tablets
10. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
11. Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant ... website. , Rod has been at the forefront of Gardant since it was founded ... Rod has overseen the opening of more than 40 new senior living communities. With ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for her ... good news for single women is that she put all the words in her ... 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... familiar. This makes it difficult for lab operators and management to assess these ... help them identify wasteful or unnecessary actions. , Created with the help ...
Breaking Medicine News(10 mins):